Athena Medtec Limited – Trademark Portfolio

Entity Type: 99

Athena Medtec Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ACCUR8. The owner is based in Surrey.

4 Langley Avenue

Surbiton

Surrey KT6 6QL , GB

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TOXBAR
TOXBAR
Pending 2025
ACCUR8
ACCUR8
Registered 2025

Trademark Classifications

Athena Medtec Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Athena Medtec Limited have?

Athena Medtec Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Athena Medtec Limited file in?

Athena Medtec Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Athena Medtec Limited's most well-known trademarks?

Athena Medtec Limited's registered trademark portfolio includes well-known marks such as ACCUR8. These are among 1 currently registered trademark in the portfolio.

What is Athena Medtec Limited's trademark registration success rate?

Athena Medtec Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.